RxDoctor Payments Data

Teresa Smith, MD

Family Medicine · Hamilton, INNPI 1730149816

Payments from drug & device makers

$408in general payments, 2019–2025

Across 25 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$81
  • AbbVie$57
  • Lilly USA, LLC$49
  • AstraZeneca$44
  • Dexcom, Inc.$33
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$31
  • plus $114 from 6 others

What the payments were for

  • Food & beverage$408100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$408 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$54,972
Medicare patients
242
Services billed
1,577

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin144$232,805
EliquisApixaban91$123,392
MounjaroTirzepatide76$119,453
OzempicSemaglutide51$92,456
TrulicityDulaglutide29$67,609
JanuviaSitagliptin Phosphate37$62,816
XareltoRivaroxaban29$49,466
FarxigaDapagliflozin Propanediol21$25,907
Breo ElliptaFluticasone/Vilanterol25$24,978
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr32$20,646
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,079
SymbicortBudesonide/Formoterol Fumarate26$14,140
Varenicline Tartrate18$7,654
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$6,870
Fluticasone-SalmeterolFluticasone Propion/Salmeterol44$6,404

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$15$232,805144 claims
Lilly USA, LLCMounjaro, Trulicity$49$187,062105 claims
Novo NordiskOzempic$81$92,45651 claims
MerckJanuvia$22$62,81637 claims
AstraZenecaFarxiga, Symbicort$44$40,04747 claims
AbbVieSynthroid$57$2,55471 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Hamilton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →